ALS Ltd. engages in the provision of analytical and testing services businesses and partnerships. The company is headquartered in Brisbane, Queensland. The firm provides comprehensive testing solutions to clients in a range of industries around the world. The firm operates through two segments: Commodities and Life Sciences. Its Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
3,194
2,999
2,461
2,279
1,951
1,761
Revenue Growth (YoY)
18%
22%
8%
17%
11%
-5%
Cost of Revenue
--
305
266
252
224
182
Gross Profit
--
2,693
2,194
2,027
1,727
1,579
Selling, General & Admin
--
1,768
1,383
1,237
1,060
1,030
Research & Development
--
--
--
--
--
--
Operating Expenses
2,738
2,268
1,765
1,587
1,381
1,311
Other Non Operating Income (Expenses)
-1
-1
-3
-2
0
--
Pretax Income
389
362
121
390
280
248
Income Tax Expense
115
103
106
114
88
74
Net Income
271
256
12
291
190
172
Net Income Growth
4,417%
2,032.99%
-96%
53%
10%
35%
Shares Outstanding (Diluted)
502.48
487.8
486.8
485.7
485.2
484.6
Shares Change (YoY)
4%
0%
0%
0%
0%
0%
EPS (Diluted)
0.54
0.52
0.02
0.59
0.39
0.35
EPS Growth
4,369%
1,882%
-96%
51%
10%
37%
Free Cash Flow
191
244
198
293
167
188
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
89.79%
89.15%
88.94%
88.51%
89.66%
Operating Margin
14.27%
14.13%
17.43%
19.26%
17.73%
15.16%
Profit Margin
8.48%
8.53%
0.48%
12.76%
9.73%
9.76%
Free Cash Flow Margin
5.97%
8.13%
8.04%
12.85%
8.55%
10.67%
EBITDA
701
657
602
591
477
399
EBITDA Margin
21.94%
21.9%
24.46%
25.93%
24.44%
22.65%
D&A For EBITDA
245
233
173
152
131
132
EBIT
456
424
429
439
346
267
EBIT Margin
14.27%
14.13%
17.43%
19.26%
17.73%
15.16%
Effective Tax Rate
29.56%
28.45%
87.6%
29.23%
31.42%
29.83%
Follow-Up Questions
What are ALS Ltd's key financial statements?
According to the latest financial statement (Form-10K), ALS Ltd has a total asset of $4,062, Net profit of $256
What are the key financial ratios for CPBLF?
ALS Ltd's Current ratio is 1.46, has a Net margin is 8.53, sales per share of $6.14.
How is ALS Ltd's revenue broken down by segment or geography?
ALS Ltd largest revenue segment is Life Sciences, at a revenue of 1,375,000,000 in the most earnings release.For geography, Americas is the primary market for ALS Ltd, at a revenue of 999,800,000.
Is ALS Ltd profitable?
yes, according to the latest financial statements, ALS Ltd has a net profit of $256